250 related articles for article (PubMed ID: 28375461)
1. Alzheimer's disease: where next for anti-amyloid therapies?
Hardy J; De Strooper B
Brain; 2017 Apr; 140(4):853-855. PubMed ID: 28375461
[No Abstract] [Full Text] [Related]
2. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
Paroni G; Bisceglia P; Seripa D
J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
Piazza F; Winblad B
J Alzheimers Dis; 2016 Mar; 52(2):417-20. PubMed ID: 27031492
[TBL] [Abstract][Full Text] [Related]
4. "Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle.
Behl T; Kaur I; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Alhazmi HA; Felemban SG; Alsubayiel AM; Bhatia S; Bungau S
Biomed Pharmacother; 2022 Apr; 148():112746. PubMed ID: 35231697
[TBL] [Abstract][Full Text] [Related]
5. [The Convergence of Alzheimer's Disease Pathogenesis Concepts].
Kozin SA; Makarov AA
Mol Biol (Mosk); 2019; 53(6):1020-1028. PubMed ID: 31876280
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid Accumulation Slows Earlier than Expected in Preclinical Alzheimer's Disease Patients.
Camara H; De-Souza EA
J Neurosci; 2018 Oct; 38(43):9123-9125. PubMed ID: 30355622
[No Abstract] [Full Text] [Related]
7. Endogenous Human Proteins Interfering with Amyloid Formation.
Gharibyan AL; Wasana Jayaweera S; Lehmann M; Anan I; Olofsson A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327638
[TBL] [Abstract][Full Text] [Related]
8. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
Cehlar O; Skrabana R; Revajova V; Novak M
Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
[TBL] [Abstract][Full Text] [Related]
9. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
10. Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism.
Chaudhuri P; Prajapati KP; Anand BG; Dubey K; Kar K
Ageing Res Rev; 2019 Dec; 56():100937. PubMed ID: 31430565
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Inhibitory Effect of GQDs-Tramiprosate Covalent Binding on Amyloid Aggregation.
Liu Y; Xu LP; Wang Q; Yang B; Zhang X
ACS Chem Neurosci; 2018 Apr; 9(4):817-823. PubMed ID: 29244487
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional molecules with a bipyridyl core ameliorate multifaceted amyloid toxicity.
Padhi D; Balachandra C; Ramesh M; Govindaraju T
Chem Commun (Camb); 2022 May; 58(43):6288-6291. PubMed ID: 35537119
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's drugs: Does reducing amyloid work?
Thambisetty M; Howard R; Glymour MM; Schneider LS
Science; 2021 Oct; 374(6567):544-545. PubMed ID: 34709898
[No Abstract] [Full Text] [Related]
14. Alzheimer's drugs: Does reducing amyloid work?-Response.
Selkoe DJ
Science; 2021 Oct; 374(6567):545-546. PubMed ID: 34709920
[No Abstract] [Full Text] [Related]
15. Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials.
Høilund-Carlsen PF; Revheim ME; Alavi A; Satyamurthy N; Barrio JR
J Alzheimers Dis; 2022; 90(4):1395-1399. PubMed ID: 36278356
[TBL] [Abstract][Full Text] [Related]
16. An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?
Hardy J; Mummery C
Brain; 2023 Apr; 146(4):1240-1242. PubMed ID: 36797987
[TBL] [Abstract][Full Text] [Related]
17. Sequence and structure-based peptides as potent amyloid inhibitors: A review.
Mitra A; Sarkar N
Arch Biochem Biophys; 2020 Nov; 695():108614. PubMed ID: 33010227
[TBL] [Abstract][Full Text] [Related]
18. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
[TBL] [Abstract][Full Text] [Related]
19. Intranasally Administered S100A9 Amyloids Induced Cellular Stress, Amyloid Seeding, and Behavioral Impairment in Aged Mice.
Iashchishyn IA; Gruden MA; Moskalenko RA; Davydova TV; Wang C; Sewell RDE; Morozova-Roche LA
ACS Chem Neurosci; 2018 Jun; 9(6):1338-1348. PubMed ID: 29618200
[TBL] [Abstract][Full Text] [Related]
20. Advancements and future directions in research of the roles of insulin in amyloid diseases.
Miller Y
Biophys Chem; 2022 Feb; 281():106720. PubMed ID: 34823073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
